Search This Blog

Friday, June 7, 2019

Stoke Therapeutics readies $100M IPO

Stoke Therapeutics (STOK) has filed a prospectus for an IPO of 6.7M common shares at $14 – 16. The offering will be valued at $100.5M at the midpoint.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)